Experimental assessment of carbacetam effect on the cerebral mitochondria in rats with scopolamine-induced Alzheimer’s disease

Kmet, Olga G.; Filipets, Nataliia D.; Yaremii, Iryna M.; Kmet, Taras I.; Vepriuk, Yurii M.; Hrachova, Tamara I.

dc.contributor.author	Kmet, Olga G.
dc.contributor.author	Filipets, Nataliia D.
dc.contributor.author	Yaremii, Iryna M.
dc.contributor.author	Kmet, Taras I.
dc.contributor.author	Vepriuk, Yurii M.
dc.contributor.author	Hrachova, Tamara I.
dc.date.accessioned	2025-04-08T12:07:28Z
dc.date.available	2025-04-08T12:07:28Z
dc.date.issued	2020
dc.identifier.other	DOI: 10.31688/ABMU.2020.55.1.01
dc.identifier.uri	http://dspace.bsmu.edu.ua:8080/xmlui/handle/123456789/26464
dc.description.abstract	The objective of the study was to evaluate the protective effect of carbacetam under conditions of mitochondrial dysfunction of the brain in rats with scopolamine-induced Alzheimer’s disease. Conclusions. Reduced intensity of mitochondrial swelling, improvement of the antioxidant system state and energy supply of mitochondria in the cerebral cortex and hippocampus of rats with scopolamine-induced Alzheimer’s disease are indicative of mitoprotective properties of carbacetam as a promising neuroprotector.	uk_UA
dc.language.iso	en	uk_UA
dc.publisher	Archives of the Balkan Medical Union (міжнародний рецензований міждисциплінарний журнал)	uk_UA
dc.subject	carbacetam	uk_UA
dc.subject	scopolamine-induced Alzheimer’s disease	uk_UA
dc.subject	functional state of the mitochondria	uk_UA
dc.title	Experimental assessment of carbacetam effect on the cerebral mitochondria in rats with scopolamine-induced Alzheimer’s disease	uk_UA
dc.type	Article	uk_UA